IMMUNIS HBV Genotype EIA - Cosmo Bio Co.,Ltd.

Antibodies

>

IMMUNIS HBV Genotype EIA

Catalog No.: IIM-1A65
Size: 48TEST
Price: ¥120000
$1600
antigen/source: HBV genotype-specific epitopes in PreS2 region
catalog info: Catalog 2012-p111
Storage: 4C
@
Immunogen: Human
Reacts with: Human
Measurement Range: 1.9 -24.8 IU/mL
Purpose: This product is an enzyme immunoassay (EIA) based HBV genotyping kit, designed to determine genotype (A, B, C, or D) by detecting genotype-specific epitopes in PreS2 region .
component: Antibody: X
Plate: X
Coating: X
Control: X
Standard: -
Labeling: X
Substrate: X
Others: X
1. Microplate coated with anti-HBs (8 wells x 12 strips) 2 plates
2. HRP-labeled mAbs (HRP-labeled anti-PreS2 mouse monoclonal antibodies)
HRP-labeled anti-'m' mAb (green) 5 mL x 1 vial
HRP-labeled anti-'k' mAb (yellow) 5 mL x 1 vial
HRP-labeled anti-'s' mAb (blue) 5 mL x 1 vial
HRP-labeled anti-'u' mAb (red) 5 mL x 1 vial)
3. Negative control 1 mL x 1 vial
4. Poitive controls
Positive control 'm' (green) 0.25 mL x 1 vial
Positive control 'k' (yellow) 0.25 mL x 1 vial
Positive control 's' (blue) 0.25 mL x 1 vial
Positive control 'u' (red) 0.25 mL x 1 vial)
5. HRP substrate (3, 3', 5, 5'-tetramethylbenzidine) 20 mL x 1 vial
6. Reaction stopper 20 mL x 1 vial
7. Washing solution (20x concentrated) 50 mL x 2 vials
8. Plate seal 6 sheets

Other:

 Supplementary 
Sandwich
 Applicable sample 
[Other]
There are eight genotypes (genotype A to H) of hepatitis B virus (HBV) which are distinguished by > 8 % difference in the nucleotide sequence of the HBV genome. Genotypes A and D are common in Europe and the United States, while genotypes B and C are prevalent in Asia. Genotype F is frequent in Latin America, while genotype E is confined to Central and Western Africa
Many studies indicate that HBV genotypes influence the severityof chronic hepatitis B and the response to interferon therapy. HBV genotypes have been determined by tedious methods such as direct sequencing, genotype-specific PCR, PCR-RFLP, line-probe assay (LiPA), or PCR-invader assay.



 IMAGE1





 IMAGE2





Reference:

•  Wan-fu Yue, Fang Zhou, Jia-biao Hu, Enoch Y. Park, Joe Hull, Yun-gen Miao. World J Microbiol Biotechnol, :11 June (2011)
•  Aoki A, Muneyuki T, Yoshida M, Munakata H, Ishikawa SE, Sugawara H, Kawakami M, Kakei M. Diabetes Res Clin Pract. May;92(2):181-6. (2011)
•  Nemoto M, Hiki Y, Shimada K, Nakai N, Fujimoto K, Inoue S, Sakurada N, Kaneko H, Sugita M, Okabe M, Sasaki T. Diabetes Technol Ther. May;13(5):509-17. (2011)
•  Ko EC, Fujihara Y, Ogasawara T, Asawa Y, Nishizawa S, Nagata S, Takato T, Hoshi K. J Biomed Mater Res A. ;97(2):186-92. (2011)
•  Sato S, Fukumura K, Nishiyama A, Kanamoto I, Inoue Y, Konishi T, Biol Pharm Bull. 33(8):1385-93 (2010)
•  Sasaki H, Asanuma H, Fujita M, Takahama H, Wakeno M, Ito S, Ogai A, Asakura M, Kim J, Minamino T, Takashima S, Sanada S, Sugimachi M, Komamura K, Mochizuki N, Kitakaze M. Circulation. May 19;119(19):2568-77. (2009)
•   Iharada M, Hiasa M, Kobara A, Moriyama Y. Biol Pharm Bull. Jul;30(7):1329-31. (2007)
•  Seki T, Kanbayashi H, Chono S, Tabata Y, Morimoto K. Int J Pharm. Jun 29;338(1-2):213-8. (2007)
•  Zhang Y, Xiao J, Lin H, Luo X, Wang H, Bai Y, Wang J, Zhang H, Yang B, Wang Z., Cell Physiol Biochem. 19(5-6):225-38. (2007)
•  Seki T, Kanbayashi H, Nagao T, Chono S, Tabata Y, Morimoto K. J Pharm Sci. Jun;95(6):1393-401. (2006)
•  Kodama T, Miyazaki T, Kitamura I, Suzuki Y, Namba Y, Sakurai J, Torikai Y, Inoue S. Eur J Clin Nutr. Mar;59(3):384-92. (2005)
 
>